Abstract
Non-albicans Candida species have acquired relevance in the last decades as a cause of serious disease. The virulence factors and antifungal susceptibility of these rare pathogens remain largely unrecognized. We examined a total of 50 yeast isolates corresponding to 11 different infrequently isolated yeast species for their in vitro enzymatic profile and susceptibility pattern as first-line antifungals. We found aspartyl protease activity for 100% of the isolates tested as well as variable DNAse, hemolysin, phospholipase and esterase activities. All strains had low MICs for amphotericin B and showed a variable response to fluconazole (0.125–32 µg/mL) and the echinocandins tested (0.25–> 8 µg/mL).
Original language | English |
---|---|
Pages (from-to) | 1147-1149 |
Number of pages | 3 |
Journal | Archives of Microbiology |
Volume | 201 |
Issue number | 8 |
DOIs | |
Publication status | Published - 1 Oct 2019 |
Bibliographical note
Funding Information:This study was supported by Programa de Apoyo a la Investigación Científica y Tecnológica (PAICyT) (no. SA-1115-15). We thank Sergio Lozano-Rodriguez, M. D., of the “Dr. José E. González” University Hospital (Monterrey, Mexico) for his review of the manuscript prior to submission.
Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
All Science Journal Classification (ASJC) codes
- Microbiology
- Biochemistry
- Molecular Biology
- Genetics